Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia

DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients

NCT00107614 ·Status: TERMINATED ·Phase: PHASE2

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

NCT04328727 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects

NCT02404025 ·Status: COMPLETED ·Phase: PHASE2

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

NCT02323178 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

NCT07231952 ·Status: RECRUITING ·Phase: PHASE2

Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases

NCT05324917 ·Status: UNKNOWN

A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia

NCT03225716 ·Status: TERMINATED ·Phase: PHASE1

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

NCT03025698 ·Status: COMPLETED ·Phase: PHASE2

Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab

NCT03384277 ·Status: COMPLETED ·Phase: PHASE4

Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects.

NCT03988608 ·Status: COMPLETED ·Phase: PHASE2

the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation

NCT02707484 ·Status: COMPLETED ·Phase: PHASE3

Anti-αIIbβ3 Immunization in Glanzmann Thrombasthenia: Prevalence and Associated Risk Factors: Thrombasthenia Anti-αIIbβ3 Antibodies Study (TAAS)

NCT04595617 ·Status: COMPLETED ·Phase: NA

Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia

NCT01231841 ·Status: COMPLETED ·Phase: PHASE2

Thrombopoietin Levels and Platelet Transfusion in Neonates

NCT00549484 ·Status: COMPLETED

Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

NCT05846529 ·Status: UNKNOWN

Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the Elderly

NCT05433922 ·Status: UNKNOWN ·Phase: NA

Gene Therapy for Wiskott-Aldrich Syndrome

NCT01515462 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

NCT07268898 ·Status: NOT_YET_RECRUITING

Registry for Vascular Anomalies Associated With Coagulopathy

NCT00576888 ·Status: COMPLETED

Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia

NCT06281327 ·Status: RECRUITING ·Phase: PHASE2

Avatrombopag Combined With IST as First-line Treatment for SAA

NCT05720234 ·Status: UNKNOWN ·Phase: PHASE2

Study of Constitutional Platelet Disease

NCT04419987 ·Status: UNKNOWN ·Phase: NA

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

NCT00726544 ·Status: TERMINATED ·Phase: PHASE2

Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

NCT02165397 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)

NCT05096403 ·Status: COMPLETED ·Phase: PHASE3